肥胖和糖尿病神经病变之间的因果关系:一个双样本的门德尔随机化研究
Zhuolin Wang1, Cong Li1, Lihui Wang1
1Changchun University of Traditional Chinese Medicine, Changchun, China.
Medicine
|February 27, 2026
概括
这项研究使用孟德尔的随机化研究调查了肥胖和糖尿病神经病变 (DN) 之间的联系. 研究结果表明,身体质量指数 (BMI) 可能对DN有保护作用,尽管其他肥胖指标显示没有显著的因果关系.
科学领域:
- 遗传学和流行病学
- 代谢障碍 代谢障碍 代谢障碍
- 神经学 神经学
背景情况:
- 肥胖越来越多地与糖尿病神经病变 (DN) 相关,但缺乏因果证据.
- 了解因果关系对于制定有效的DN预防和治疗策略至关重要.
- 门德尔随机化 (MR) 提供了一个强大的方法,可以从观测数据中推断因果关系.
研究的目的:
- 调查肥胖指标和糖尿病神经病变 (DN) 之间的潜在因果关系.
- 评估身体质量指数 (BMI),腰围 (WC),部周长 (HC) 和腰与部比率 (WHR) 是否对DN风险产生因果影响.
主要方法:
- 使用与DN相关的遗传变异进行了门德尔随机化 (MR) 分析.
- 针对肥胖度 (BMI,WC,HC,WHR) 的全基因组关联研究 (GWAS) 的总结统计数据被利用.
- 用逆变量加权 (IVW),MR-Egger和加权中位数方法来估计因果关系,并进行了灵敏度分析.
主要成果:
- 反变权加权分析表明,BMI,WC和HC与DN风险之间存在显著的负相关性.
- 经过邦费罗尼校正后,BMI和DN之间发现了统计学上显著的因果关系.
- 没有观察到与DN的WC,HC或WHR有显著的因果关系,BMI显示了潜在的轻微保护作用.
结论:
- 体重指数 (BMI) 可能会对患糖尿病神经病变 (DN) 的风险产生保护作用.
- 这项研究提供了基因证据,支持BMI和DN之间的因果关系.
- 需要进一步的研究来阐明肥胖指标和DN病原体之间的复杂相互作用.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
Carbohydrate Metabolism
14.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.6K
Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
324
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
Diabetes Mellitus: Overview and Type I Subtype
5.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K

